ArticleMSMR2024
Syphilis cases among pregnant women and newborns in the Military Health System, 2012-2022.
Article in MSMR, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This report presents the rates of maternal syphilis among pregnant women and congenital syphilis among newborns in the Military Health System (MHS) beneficiary population from 2012 to 2022. Medical encounter data from military hospitals and clinics as well as civilian health care facilities were obtained from the Defense Medical Surveillance System (DMSS) to determine pregnancies, live births, and confirmed diagnoses of maternal and congenital syphilis. The rate of maternal syphilis in female MHS beneficiaries increased by 233% between 2012 (n=123, 66.0 per 100,000 births) and 2022 (n=169, 219.8 per 100,000 births), while the rate of congenital syphilis in newborn MHS beneficiaries increased by 355% (n=9 to n=32, 6.8 to 30.8 per 100,000 live births). Pregnant active component service members generally evinced higher rates of maternal syphilis than pregnant non-service member MHS beneficiaries during the reporting period. Additionally, the positive predictive value of maternal syphilis cases in the MHS was found to be low (59%). Future studies could focus on potential misclassification of maternal syphilis cases as well as syphilis screening compliance and treatment during pregnancy for all pregnant MHS beneficiaries. The rate of diagnosed maternal syphilis among pregnant female active component service members exceeded previously reported rates of syphilis among all female active component service members annually between 2015 and 2022, likely due to increased screening.
Indexed as
Identifiers
39736158PMC11741559What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.